enVVeno Medical Corporation (NVNO)
USD 2.26
(-9.07%)
USD 2.26
(-9.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 48.63 Million USD | 16.74% |
| 2022 | 41.66 Million USD | -27.8% |
| 2021 | 57.69 Million USD | 447.54% |
| 2020 | 10.53 Million USD | 206.85% |
| 2019 | 3.43 Million USD | -3.52% |
| 2018 | 3.55 Million USD | 60.71% |
| 2017 | 2.21 Million USD | 24.23% |
| 2016 | 1.78 Million USD | -37.98% |
| 2015 | 2.87 Million USD | 79.95% |
| 2014 | 1.59 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 50.39 Million USD | 22.92% |
| 2024 Q2 | 40.99 Million USD | -8.55% |
| 2024 Q1 | 44.82 Million USD | -7.83% |
| 2023 Q1 | 36.61 Million USD | -12.12% |
| 2023 FY | 48.63 Million USD | 16.74% |
| 2023 Q3 | 28.09 Million USD | -12.44% |
| 2023 Q4 | 48.63 Million USD | 73.12% |
| 2023 Q2 | 32.08 Million USD | -12.36% |
| 2022 Q1 | 54.22 Million USD | -6.02% |
| 2022 Q3 | 45.45 Million USD | -8.96% |
| 2022 Q4 | 41.66 Million USD | -8.35% |
| 2022 Q2 | 49.93 Million USD | -7.92% |
| 2022 FY | 41.66 Million USD | -27.8% |
| 2021 Q2 | 42.35 Million USD | -6.0% |
| 2021 Q1 | 45.05 Million USD | 327.55% |
| 2021 FY | 57.69 Million USD | 447.54% |
| 2021 Q4 | 57.69 Million USD | -2.49% |
| 2021 Q3 | 59.17 Million USD | 39.71% |
| 2020 Q2 | 3.73 Million USD | 34.79% |
| 2020 Q1 | 2.76 Million USD | -19.35% |
| 2020 Q3 | 7.04 Million USD | 88.64% |
| 2020 FY | 10.53 Million USD | 206.85% |
| 2020 Q4 | 10.53 Million USD | 49.63% |
| 2019 Q4 | 3.43 Million USD | -40.29% |
| 2019 FY | 3.43 Million USD | -3.52% |
| 2019 Q3 | 5.75 Million USD | -20.7% |
| 2019 Q2 | 7.25 Million USD | 32.16% |
| 2019 Q1 | 5.48 Million USD | 54.18% |
| 2018 Q3 | 5.43 Million USD | -24.56% |
| 2018 Q4 | 3.55 Million USD | -34.52% |
| 2018 FY | 3.55 Million USD | 60.71% |
| 2018 Q1 | 2.8 Million USD | 26.42% |
| 2018 Q2 | 7.2 Million USD | 157.34% |
| 2017 FY | 2.21 Million USD | 24.23% |
| 2017 Q2 | 1.73 Million USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 Q3 | 1.93 Million USD | 11.52% |
| 2017 Q4 | 2.21 Million USD | 14.69% |
| 2016 FY | 1.78 Million USD | -37.98% |
| 2016 Q4 | 1.78 Million USD | -6.52% |
| 2016 Q3 | 1.9 Million USD | 0.0% |
| 2016 Q1 | - USD | -100.0% |
| 2015 FY | 2.87 Million USD | 79.95% |
| 2015 Q4 | 2.87 Million USD | 0.0% |
| 2014 FY | 1.59 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -55.056% |
| BrainsWay Ltd. | 62.97 Million USD | 22.767% |
| Cerus Corporation | 197.74 Million USD | 75.406% |
| Envoy Medical, Inc. | 7.64 Million USD | -536.584% |
| electroCore, Inc. | 16.38 Million USD | -196.79% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -532.28% |
| IceCure Medical Ltd | 16.41 Million USD | -196.374% |
| Inogen, Inc. | 326.19 Million USD | 85.09% |
| OrthoPediatrics Corp. | 449.58 Million USD | 89.182% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -78.346% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -193.353% |
| MaxCyte, Inc. | 268.27 Million USD | 81.871% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -500.631% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1239.1% |
| Orthofix Medical Inc. | 925.31 Million USD | 94.744% |
| PAVmed Inc | 33.11 Million USD | -46.849% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 66.097% |
| RxSight, Inc. | 182.55 Million USD | 73.358% |
| Sight Sciences, Inc. | 166.65 Million USD | 70.816% |
| SI-BONE, Inc. | 230.42 Million USD | 78.893% |
| TELA Bio, Inc. | 78.04 Million USD | 37.686% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 80.693% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -353.262% |
| Acutus Medical, Inc. | 53.96 Million USD | 9.868% |
| Talis Biomedical Corporation | 98.34 Million USD | 50.544% |
| Spectral AI, Inc. | 10.69 Million USD | -354.873% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 77.756% |
| CVRx, Inc. | 115.22 Million USD | 57.793% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 17.091% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1461.189% |
| Bioventus Inc. | 810.91 Million USD | 94.002% |
| Venus Concept Inc. | 93.65 Million USD | 48.069% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -89.057% |
| LivaNova PLC | 2.42 Billion USD | 97.998% |
| 908 Devices Inc. | 202.98 Million USD | 76.04% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 93.96% |
| Nemaura Medical Inc. | 14.56 Million USD | -233.957% |
| NeuroPace, Inc. | 107.65 Million USD | 54.822% |
| LENSAR, Inc. | 69.58 Million USD | 30.107% |
| Apyx Medical Corporation | 79.24 Million USD | 38.623% |
| Cutera, Inc. | 346.29 Million USD | 85.955% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -15.754% |
| BioSig Technologies, Inc. | 1.79 Million USD | -2604.95% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 82.029% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -14.003% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 98.714% |
| Axonics, Inc. | 719.92 Million USD | 93.244% |
| Outset Medical, Inc. | 313.8 Million USD | 84.501% |
| IRIDEX Corporation | 34.43 Million USD | -41.233% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 87.983% |
| IRadimed Corporation | 92.15 Million USD | 47.225% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -825.676% |
| INVO Bioscience, Inc. | 20.88 Million USD | -132.839% |
| Telesis Bio, Inc. | 70.41 Million USD | 30.927% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 68.44% |
| Varex Imaging Corporation | 1.24 Billion USD | 96.108% |
| Quipt Home Medical Corp. | 247.4 Million USD | 80.342% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -422.395% |
| Pulmonx Corporation | 178.95 Million USD | 72.822% |
| Dynatronics Corporation | 25.94 Million USD | -87.486% |
| Modular Medical, Inc. | 13.8 Million USD | -252.249% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -353.389% |
| Semler Scientific, Inc. | 78.06 Million USD | 37.699% |
| InMode Ltd. | 863.28 Million USD | 94.366% |
| Bruker Corporation | 4.24 Billion USD | 98.856% |
| Cytosorbents Corporation | 53.26 Million USD | 8.685% |
| DexCom, Inc. | 6.26 Billion USD | 99.224% |
| Align Technology, Inc. | 6.08 Billion USD | 99.201% |
| Viveve Medical, Inc. | 25.91 Million USD | -87.686% |
| ZimVie Inc. | 1.2 Billion USD | 95.965% |
| Movano Inc. | 9.42 Million USD | -416.24% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 90.227% |
| Nexalin Technology, Inc. | 3.63 Million USD | -1239.1% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 17.091% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 94.895% |
| Profound Medical Corp. | 43.68 Million USD | -11.328% |
| Insulet Corporation | 2.58 Billion USD | 98.121% |
| Surmodics, Inc. | 185.73 Million USD | 73.815% |
| iCAD, Inc. | 41.41 Million USD | -17.425% |
| Nuwellis, Inc. | 9.77 Million USD | -397.799% |
| Biotricity, Inc. | 5.94 Million USD | -718.409% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 88.772% |
| Aethlon Medical, Inc. | 8.24 Million USD | -489.802% |
| InspireMD, Inc. | 47.64 Million USD | -2.082% |
| PAVmed Inc. | 33.11 Million USD | -46.849% |
| BIOLASE, Inc. | 35.1 Million USD | -38.557% |
| Beyond Air, Inc. | 56.96 Million USD | 14.617% |
| FONAR Corporation | 214.24 Million USD | 77.299% |
| AxoGen, Inc. | 196.82 Million USD | 75.29% |
| Vivani Medical, Inc. | 45.79 Million USD | -6.197% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 82.719% |
| Inari Medical, Inc. | 674.23 Million USD | 92.787% |
| UFP Technologies, Inc. | 404.13 Million USD | 87.966% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -107.855% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -411.78% |
| Tenon Medical, Inc. | 6.34 Million USD | -666.509% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -417.009% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 53.077% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.947% |
| Sintx Technologies, Inc. | 15.36 Million USD | -216.531% |
| NanoVibronix, Inc. | 6.67 Million USD | -628.723% |
| Quanterix Corporation | 425.01 Million USD | 88.557% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -422.395% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 9.478% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 97.215% |
| TransMedics Group, Inc. | 706.04 Million USD | 93.112% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 23.036% |
| NeuroMetrix, Inc. | 21.42 Million USD | -127.007% |
| Hyperfine, Inc. | 94.19 Million USD | 48.37% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 81.896% |
| Biomerica, Inc. | 9.25 Million USD | -425.557% |
| Bone Biologics Corporation | 3.73 Million USD | -1201.179% |
| AVITA Medical, Inc. | 144.33 Million USD | 66.305% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -898.967% |
| Silk Road Medical, Inc | 265.3 Million USD | 81.669% |